147 related articles for article (PubMed ID: 26870273)
1. Pantoprazole inhibits human gastric adenocarcinoma SGC-7901 cells by downregulating the expression of pyruvate kinase M2.
Shen Y; Chen M; Huang S; Zou X
Oncol Lett; 2016 Jan; 11(1):717-722. PubMed ID: 26870273
[TBL] [Abstract][Full Text] [Related]
2. LY294002 inhibits the Warburg effect in gastric cancer cells by downregulating pyruvate kinase M2.
Lu J; Chen M; Gao S; Yuan J; Zhu Z; Zou X
Oncol Lett; 2018 Apr; 15(4):4358-4364. PubMed ID: 29541204
[TBL] [Abstract][Full Text] [Related]
3. Pyruvate kinase M2 contributes to cell growth in gastric cancer via aerobic glycolysis.
Li H; Xu H; Xing R; Pan Y; Li W; Cui J; Lu Y
Pathol Res Pract; 2019 Jun; 215(6):152409. PubMed ID: 31000383
[TBL] [Abstract][Full Text] [Related]
4. Shikonin Inhibits Tumor Growth in Mice by Suppressing Pyruvate Kinase M2-mediated Aerobic Glycolysis.
Zhao X; Zhu Y; Hu J; Jiang L; Li L; Jia S; Zen K
Sci Rep; 2018 Sep; 8(1):14517. PubMed ID: 30266938
[TBL] [Abstract][Full Text] [Related]
5. Effects of pantoprazole as a HIF-1α inhibitor on human gastric adenocarcinoma sgc-7901 cells.
Shen Y; Wu Y; Chen M; Shen W; Huang S; Zhang L; Zou X
Neoplasma; 2012; 59(2):142-9. PubMed ID: 22248271
[TBL] [Abstract][Full Text] [Related]
6. p,p'-Dichlorodiphenyltrichloroethane promotes aerobic glycolysis via reactive oxygen species-mediated extracellular signal-regulated kinase/M2 isoform of pyruvate kinase (PKM2) signaling in colorectal cancer cells.
Song L; Dong N; Li Z
Environ Toxicol; 2020 Mar; 35(3):333-345. PubMed ID: 31724279
[TBL] [Abstract][Full Text] [Related]
7. Rab25 acts as an oncogene and participates in the regulation of aerobic glycolysis via PKM2 in gastric adenocarcinoma.
Zheng T; Huang L; Chen N; Xue H; Ni P; Huang G
Transl Cancer Res; 2021 Feb; 10(2):790-805. PubMed ID: 35116410
[TBL] [Abstract][Full Text] [Related]
8. Small ubiquitin-like modifier 1 modification of pyruvate kinase M2 promotes aerobic glycolysis and cell proliferation in A549 human lung cancer cells.
An S; Huang L; Miao P; Shi L; Shen M; Zhao X; Liu J; Huang G
Onco Targets Ther; 2018; 11():2097-2109. PubMed ID: 29713182
[TBL] [Abstract][Full Text] [Related]
9. Pyruvate Kinase M2 Mediates Glycolysis Contributes to Psoriasis by Promoting Keratinocyte Proliferation.
Liu YZ; Xu MY; Dai XY; Yan L; Li L; Zhu RZ; Ren LJ; Zhang JQ; Zhang XF; Li JF; Tian YJ; Shi WJ; Liu YQ; Jiang CL; Zhu JB; Chen JK
Front Pharmacol; 2021; 12():765790. PubMed ID: 34733164
[TBL] [Abstract][Full Text] [Related]
10. Pyruvate kinase M2 affects liver cancer cell behavior through up-regulation of HIF-1α and Bcl-xL in culture.
Dong T; Yan Y; Chai H; Chen S; Xiong X; Sun D; Yu Y; Deng L; Cheng F
Biomed Pharmacother; 2015 Feb; 69():277-84. PubMed ID: 25661370
[TBL] [Abstract][Full Text] [Related]
11. Follicle-stimulating hormone promoted pyruvate kinase isozyme type M2-induced glycolysis and proliferation of ovarian cancer cells.
Li S; Ji X; Wang R; Miao Y
Arch Gynecol Obstet; 2019 May; 299(5):1443-1451. PubMed ID: 30809696
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine Kinase Signaling in Cancer Metabolism: PKM2 Paradox in the Warburg Effect.
Wiese EK; Hitosugi T
Front Cell Dev Biol; 2018; 6():79. PubMed ID: 30087897
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of PKM2 induces apoptosis and autophagy in human A549 alveolar adenocarcinoma cells.
Chu B; Wang J; Wang Y; Yang G
Mol Med Rep; 2015 Sep; 12(3):4358-4363. PubMed ID: 26082202
[TBL] [Abstract][Full Text] [Related]
14. MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in gastric cancer.
Tang R; Yang C; Ma X; Wang Y; Luo D; Huang C; Xu Z; Liu P; Yang L
Oncotarget; 2016 Feb; 7(5):5972-84. PubMed ID: 26745603
[TBL] [Abstract][Full Text] [Related]
15. PKM2 and cancer: The function of PKM2 beyond glycolysis.
Dong G; Mao Q; Xia W; Xu Y; Wang J; Xu L; Jiang F
Oncol Lett; 2016 Mar; 11(3):1980-1986. PubMed ID: 26998110
[TBL] [Abstract][Full Text] [Related]
16. Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in mice.
Shi HS; Li D; Zhang J; Wang YS; Yang L; Zhang HL; Wang XH; Mu B; Wang W; Ma Y; Guo FC; Wei YQ
Cancer Sci; 2010 Jun; 101(6):1447-53. PubMed ID: 20507318
[TBL] [Abstract][Full Text] [Related]
17. OSU-A9 induced-reactive oxygen species cause cytotoxicity in duodenal and gastric cancer cells by decreasing phosphorylated nuclear pyruvate kinase M2 protein levels.
Chiu CF; Weng JR; Lee SL; Wu CY; Chu PC; Shan YS; Yang HR; Bai LY
Biochem Pharmacol; 2020 Apr; 174():113811. PubMed ID: 31954719
[TBL] [Abstract][Full Text] [Related]
18. Targeting pyruvate kinase M2 contributes to radiosensitivity of non-small cell lung cancer cells in vitro and in vivo.
Meng MB; Wang HH; Guo WH; Wu ZQ; Zeng XL; Zaorsky NG; Shi HS; Qian D; Niu ZM; Jiang B; Zhao LJ; Yuan ZY; Wang P
Cancer Lett; 2015 Jan; 356(2 Pt B):985-93. PubMed ID: 25444918
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of Pyruvate Kinase M2 Inhibits Cell Proliferation, Metabolism, and Migration in Renal Cell Carcinoma.
Dey P; Son JY; Kundu A; Kim KS; Lee Y; Yoon K; Yoon S; Lee BM; Nam KT; Kim HS
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717694
[TBL] [Abstract][Full Text] [Related]
20. Pyruvate kinase M2: A multifarious enzyme in non-canonical localization to promote cancer progression.
Amin S; Yang P; Li Z
Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):331-341. PubMed ID: 30826427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]